Effects of Video Game on Patients With Knee Osteoarthritis

Knee Osteoarthritis Clinical Trial

Official title:

Therapeutic Effects Video Game Play Therapy on Patients With Knee Osteoarthritis: a Single Blind, Randomized-controlled Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03198845
• Other study ID #: MOST 103-2314-B-341-002
• Status: Completed
• Phase: N/A
• First received: June 23, 2017
• Last updated: June 23, 2017
• Start date: August 1, 2014
• Est. completion date: July 31, 2015

Study information

• Verified date: June 2017
• Source: Taipei Medical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To investigate the effects of video game play therapy in patients with knee osteoarthritis

Description:

A total of 80 patients with knee osteoarthritis were randomized into two groups, including video game group and exercise group.

Physical activity, quality of life, emotion, and balance were assessed at before treatment and follow-up assessments, including at after 2 week of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated, respectively.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: July 31, 2015
• Est. primary completion date: July 31, 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 85 Years

Eligibility

Inclusion Criteria:

• Knee osteoarthritis with Kellgren/Lawrence grade II of greater ambulatory for more than 15 meters without support or orthosis usage

Exclusion Criteria:

• Knee operation history participants with pregnancy stroke history infection or fracture over lower limbs previously

Related Conditions & MeSH terms

• Knee Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Knee

Intervention

Other:
• video game
20-min per session for 3 times per week for a 4-week duration
• exercise
20-min per session for 3 times per week for a 4-week duration

Locations

Country	Name	City	State
Taiwan	Shin Kong Wu Ho-Su Memorial Hospital	Taipei

Sponsors (2)

Lead Sponsor	Collaborator
Taipei Medical University	Shin Kong Wu Ho-Su Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	change of disability	Graded chronic pain scale	scores change from baseline to after 2 weeks of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated.
Other	change of work ability	Work ability index	scores change from baseline to after 2 weeks of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated.
Other	change of balance	Biodex Stability System	scores change from baseline to after 2 weeks of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated.
Other	change of stairs climbing time	stairs climbing time	time change from baseline to after 2 weeks of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated.
Other	change of walking time	walking 10-m time	time change from baseline to after 2 weeks of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated.
Primary	change of Western Ontario and McMaster Universities Osteoarthritis index	Western Ontario and McMaster Universities Osteoarthritis index	scores change from baseline to after 2 weeks of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated.
Secondary	change of quality of life	World Health Organization-Quality of life-Brief Vision	scores change from baseline to after 2 weeks of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated.
Secondary	change of emotion	Hospital Anxiety and Depression Scale	scores change from baseline to after 2 weeks of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated.
Secondary	change of fatigue	Multidimensional Fatigue Inventory	scores change from baseline to after 2 weeks of treatment; after 4 weeks of treatment; and 1 and 3 months after treatment is terminated.